Clinical presentation and evolution of isolated focal and segmental dystonia in adults – 20 years experience from a botulinum toxin clinic
Objective: To provide unique data on the common patterns of muscles selected for injection and the time course of benefit and weakness for BoNT injections…Treatment of upper limb dystonic tremors: a retrospective study
Objective: Our study aimed to evaluate the clinical outcome of patients with upper-limb dystonic tremor (UL-DTs) treated at a tertiary hospital in London. Background: Tremor…Impact of botulinum toxin treatment on gait in focal dystonia
Objective: To study the effects of botulinum neurotoxin (BTX) treatment on gait characteristics in patients with blepharospasm and cervical dystonia. Background: The impact of focal…Changes in botulinum toxin dosing in cervical dystonia over 7 years
Objective: To assess changes in botulinum toxin dosing over the course of illness of cervical dystonia. Background: Muscle specific botulinum toxin injections remains the main…Use of bupivacaine in the evaluation of acute secondary cervical dystonia (CD)
Objective: To highlight the potential use of bupivacaine/analgesics in assessing cervical dystonia, where disabling local pain can be a confounder and limits clinical examination. Background:…Botulinum Toxin Therapy for Medication and DBS Refractory Foot Dystonia of Parkinsonism
Objective: To determine efficacy and safety of BTX therapy in patients with medically refractory foot dystonia secondary to Parkinson’s disease (PD) or atypical Parkinsonism (AP)…Application of Goal Attainment Scale as a patient-centered assessment for cervical dystonia
Objective: To explore the goal attainment scale (GAS) by interviewing the three most disturbing problems and changes after Botulinum toxin A injection in cervical dystonia…Oropharyngeal Dysphagia Before and After Botulinum Toxin Injection in Cervical Dystonia
Objective: 1.To determine if Botulinum toxin (BoNT) injection improves oropharyngeal swallowing in individuals with cervical dystonia (CD) as determined by objective data from videofluorographic swallowing studies…PHENOTYPIC DESCRIPTION OF TWO UNREPORTED FAMILIES WITH ANO3 DYSTONIA
Objective: This is the phenotypic description of two families affected by hereditary dystonia associated to gene ANO3 mutation (DYT24), one with a heterozygous verisimilarly pathogenic…Characterization of routine botulinum toxin (BoNT) therapy and patient population in cervical dystonia
Objective: We conducted a survey to characterize real-world treatment of CD patients with focus on treatment duration, clinical parameters and awareness of clinical resistance as…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 19
- Next Page »